ArticleComputational and structural biotechnology journal2026
Exact Formula of the Total Quasi-Steady State Approximation in Competitive Target-Mediated Drug Disposition.
Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Competitive target-mediated drug disposition (competitive TMDD) arises when 2 drugs compete for the same target receptor. The full competitive TMDD model characterizes these dynamics; yet, its complexity motivated the use of a reduced model, which is invalid under high receptor concentrations. While this problem can be resolved by using the total quasi-steady state approximation, which remains valid for broad parameter regimes, the exact formula of the total quasi-steady state approximation-based reduced model-competitive qTMDD-remained unknown for 15 years, as it requires solving a cubic equation and identifying a biologically meaningful solution. Consequently, researchers have relied on computationally expensive numerical approximations, limiting practical applicability. Here, we derive-for the first time-a real-valued exact formula for competitive qTMDD by leveraging analytic properties of cubic equations and geometric characteristics of their roots in the complex plane. This formulation improved computational speed by approximately 18-fold compared to numerical approximation methods, enabling competitive qTMDD-based Bayesian inference that was previously impractical. Applied to clinical trial data for anakinra and rhIL-7-hyFc, competitive qTMDD estimated pharmacological parameters comparable to those from the full competitive TMDD model while requiring only approximately 28% of the computation time. Importantly, it maintains robust accuracy even at low sampling density, whereas previous reduced models exhibit bias. By ensuring precise biological interpretation of drug systems even in complex real-world scenarios, the exact formula of competitive qTMDD has the potential to streamline the drug development and clinical testing process. Our exact formula also consists entirely of real-valued terms, allowing seamless integration into existing pharmacometrics software.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.